Patent details

Basic Information

Publication number:

EP3686194

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP201579273

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS

French Title of Invention:

COMPOSÉS DE 2-(ANILINO 2,4,5-SUBSTITUÉ)PYRIMIDINE

German Title of Invention:

2-(2,4,5-SUBSTITUIERTE ANILINO)PYRIMIDINVERBINDUNGEN

SPC Number:

Dates

Filing date:

25/07/2012

Grant date:

15/09/2021

EP Publication Date:

29/07/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/09/2021

EP B1 Publication Date:

15/09/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/07/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/09/2021

 

 

Name:

Astrazeneca AB

Address:

Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

28/10/2021

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

KADAMBAR, Vasantha, Krishna

Address:

United Kingdom (GB)

2

Name:

REDFEARN, Heather, Marie

Address:

United Kingdom (GB)

3

Name:

BUTTERWORTH, Sam

Address:

United Kingdom (GB)

4

Name:

CHINTAKUNTLA, Chandrasekhara, Reddy

Address:

United Kingdom (GB)

5

Name:

WARD, Richard Andrew

Address:

United Kingdom (GB)

6

Name:

CHUAQUI, Claudio, Edmundo

Address:

United States (US)

7

Name:

MURUGAN, Andiappan

Address:

United Kingdom (GB)

8

Name:

FINLAY, Maurice Raymond Verschoyle

Address:

United Kingdom (GB)

Priority

1

Priority Number:

201161512061 P

Priority Date:

27/07/2011

Priority Country:

United States (US)

2

Priority Number:

201261591363 P

Priority Date:

27/01/2012

Priority Country:

United States (US)

Classification

IPC classification:

C07D 401/02; C07D 471/04; A61K 31/506; A61K 31/437; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202137

Publication date:

15/09/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/07/2025

Annual Fee Number:

14

Annual Fee Amount:

198 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/07/2024

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
28/10/2021	Outgoing Correspondence	1
28/10/2021	Power Of Attorney	1